Genetically Reengineered K562 Cells Significantly Expand Cord Blood (CB) Natural Killer (NK) Cells Ex-Vivo Expanded with Increased NK Cell Activation and Cytolytic Activity Both In-Vitro and In-Vivo: Potential Use In Adoptive Cellular Immunotherapy (ACI)

被引:0
|
作者
Levin, Michele
Ayello, Janet [1 ]
Zhao, Frances [1 ]
Stier, Andrew
Tiffen, Lauren
Quish, William
vandeVen, Carmella [1 ]
Baxi, Laxmi V.
Hochberg, Jessica [2 ]
Cairo, Mitchell S. [1 ]
机构
[1] Columbia Univ, Morgan Stanley Childrens Hosp New York Presbyteri, New York, NY USA
[2] New York Med Coll, Valhalla, NY 10595 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1602 / 1602
页数:1
相关论文
共 20 条
  • [1] GENETICALLY REENGINEERED K562 CELLS SIGNIFICANTLY EXPAND CORD BLOOD (CB) NATURAL KILLER (NK) CELLS WITH INCREASED CYTOLYTIC ABILITY FOR POTENTIAL USE IN ADOPTIVE CELLULAR IMMUNOTHERAPY (ACI)
    Cairo, M.
    Hochberg, J.
    Zhao, F.
    van de Ven, C.
    Ayello, J.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S15 - S16
  • [2] GENETICALLY REENGINEERED K562 CELLS SIGNIFICANTLY EXPAND CORD BLOOD (CB) NATURAL KILLER (NK) CELLS FOR USE IN ADOPTIVE CELLULAR IMMUNOTHERAPY
    Hochberg, J.
    Ayello, J.
    Van de Ven, C.
    Campana, D.
    Cairo, M.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S70 - S71
  • [3] GENETICALLY REENGINEERED K562 CELLS (ANTIGEN PRESENTING CELLS, APC) SIGNIFICANTLY EXPAND CORD BLOOD (CB) NATURAL KILLER (NK) CELLS FOR USE IN ADOPTIVE CELLULAR IMMUNOTHERAPY
    Hochberg, Jessica
    Mar, Brenton
    Ayello, Janet
    van de Ven, Carmella
    Ricci, Angela
    Gurnani, Lalit
    Campana, Dario
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 698 - 698
  • [4] Enhanced NK cell activation, cytotoxicity and ex-vivo expansion (EvE) of cryopreserved cord blood (CB) natural killer (NK) cells: Potential role for CBNK cells in adoptive cellular immunotherapy (ACI).
    Ayello, Janet
    Nemiroff, Julia
    Satwani, Prakash
    van de Ven, Carmella
    Shereck, Evan
    Lomerzow, Whitney
    Wapner, Ronald
    Baxi, Laxmi
    Cairo, Mitchell S.
    BLOOD, 2006, 108 (11) : 218A - 218A
  • [5] Optimal ex-vivo expansion (EvE) of cord blood (CB) natural killer (NK) cells, NK cytotoxicity and NK receptor (NKR) expression: Potential for CB adoptive cellular immunotherapy (ACI).
    Ayello, J
    Satwani, P
    Van de Ven, C
    Roman, E
    Baxi, L
    Kurtzburg, J
    Cairo, MS
    BLOOD, 2005, 106 (11) : 14A - 15A
  • [6] Activation and enhancement of ex vivo (EvE) expanded cryopreserved cord blood (CB) natural killer (NK) cells, cytolytic potential, and NK receptor (NKR) expression: Potential role for CBNK in adoptive cellular immunotherapy (ACI)
    Ayello, F
    Satwani, P
    Lomazow, W
    van de Ven, C
    Roman, E
    Shereck, E
    Baxi, L
    Kurtzberg, J
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 103 - 104
  • [7] Ex-vivo expansion (EvE) of previously cryopreserved cord blood (CB) into natural killer (NK) cells with enhanced aml and neuroblastoma cytotoxicity: Potential role of cb nk cells in adoptive cellular immunotherapy (ACI)
    Ayello, J.
    Satwani, P.
    van de Ven, C.
    Shereck, E.
    Roman, E.
    Wapner, R. J.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 10 - 11
  • [8] SIGNIFICANT EX-VIVO EXPANSION OF CORD BLOOD (CB) NATURAL KILLER (NK) CELLS AND CONCOMITANT DECREASE IN CB T-CELLS BY GENETICALLY REENGINEERED K562 CELLS (K562-MBIL15-41BBL)
    Hochberg, J.
    Mar, B.
    Ayello, J.
    Day, N.
    van de Ven, C.
    Ricci, A.
    Gurnani, L.
    Cairo, E.
    Campana, D.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 44 - 45
  • [9] ENHANCED NATURAL KILLER (NK) AND NK T CELL ACTIVATION, EXPANSION AND CYTOKINE PROTEIN PRODUCTION FOLLOWING EX-VIVO ENGINEERING (EvE) OF PREVIOUSLY CRYOPRESERVED CORD BLOOD (CB): POTENTIAL FOR CB NK AND NK T CELLS IN ADOPTIVE CELLULAR IMMUNOTHERAPY (ACI)
    Ayello, J.
    Sugarman, E.
    Day, N.
    Hochberg, J.
    Mar, B.
    Cairo, E.
    van de Ven, C.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 42 - 43
  • [10] A NOVEL METHOD OF GENETICALLY ENGINEERED K562 CELLS TO SIGNIFICANTLY EXPAND CORD BLOOD (CB) NK CELLS AND INCREASE CB NK RECEPTOR EXPRESSION AND NK CELL ACTIVATION
    Hochberg, J.
    Ayello, J.
    van de Ven, C.
    Baxi, L.
    Zhao, F.
    Cairo, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S166 - S167